Literature DB >> 16728055

Endoscopic embryo collection and embryo transfer into the oviduct and the uterus of pigs.

U Besenfelder1, J Mödl, M Müller, G Brem.   

Abstract

We describe the first complete embryo transfer program, including flushing of embryos from the oviducts via the uterine horns, transfer of embryos into the Fallopian tubes or the uterine horns and recording of the number of piglets born live. The described procedure is minimally invasive and allows the use of pigs simultaneously for embryo collection and production of normal pregnancies. A 30 degrees forward oblique endoscope provided optimal visualization of the reproductive organs and free access to the organs for embryo flushing and transfer. In contrast to surgical and nonsurgical methods, endoscopy allows to pre-examine the genital tract for reproductive abnormalities and successful ovulation. A total of 95 prepuberal gilts or cyclic sows were used in this trial. Embryos or oocytes were collected from hormonally treated pigs via endoscopy(n = 17) on Day 3 and via laparotomy or post mortem after slaughter (control group, n = 38) on Day 3 and 6 after insemination. One (unilateral collection, n = 7) or both oviducts (bilateral collection, n = 10) were flushed endoscopically. We recovered 114 (average 16/pig) and 279 (average 28/pig) oocytes or embryos with fertilization rates of 89% and 72%, respectively. In the control group 834 oocytes or embryos were collected at Day 3 and 6 after insemination (fertilization rate 64%, total 534 embryos, 33 at 2-, 367 at 4-, 2 at 8-cell stage, 24 morulae and 108 blastocysts). Of 836 embryos recovered by endoscopy, surgery or slaughter 528 Day 3 embryos at 2- to 4-cell stage were transferred into (one) oviducts (n = 27 pigs, about 20/pig) resulting in 9 pregnant pigs diagnosed at Day 28 by sonography. Of the 9, 8 carried a total of 49 piglets to term. A total of 195 Day 6 embryos were transferred into uterine horns (n = 12 pigs, about 16/pig), resulting in 5 pregnant pigs carrying a total of 38 offspring to term. The use of endoscopy in assisted reproduction of pigs has the advantages of allowing easy access to the ovary, oviduct and uterus, clear view of the organ manipulation without exposure and exteriorization of viscera during surgery.

Entities:  

Year:  1997        PMID: 16728055     DOI: 10.1016/s0093-691x(97)00062-9

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  9 in total

1.  Sequential targeting of CFTR by BAC vectors generates a novel pig model of cystic fibrosis.

Authors:  N Klymiuk; L Mundhenk; K Kraehe; A Wuensch; S Plog; D Emrich; M C Langenmayer; M Stehr; A Holzinger; C Kröner; A Richter; B Kessler; M Kurome; M Eddicks; H Nagashima; K Heinritzi; A D Gruber; E Wolf
Journal:  J Mol Med (Berl)       Date:  2011-12-15       Impact factor: 4.599

2.  Direct introduction of gene constructs into the pronucleus-like structure of cloned embryos: a new strategy for the generation of genetically modified pigs.

Authors:  Mayuko Kurome; Simon Leuchs; Barbara Kessler; Elisabeth Kemter; Eva-Maria Jemiller; Beatrix Foerster; Nikolai Klymiuk; Valeri Zakhartchenko; Eckhard Wolf
Journal:  Transgenic Res       Date:  2016-12-10       Impact factor: 2.788

3.  Potential of primary kidney cells for somatic cell nuclear transfer mediated transgenesis in pig.

Authors:  Anne Richter; Mayuko Kurome; Barbara Kessler; Valeri Zakhartchenko; Nikolai Klymiuk; Hiroshi Nagashima; Eckhard Wolf; Annegret Wuensch
Journal:  BMC Biotechnol       Date:  2012-11-09       Impact factor: 2.563

4.  Xenografted islet cell clusters from INSLEA29Y transgenic pigs rescue diabetes and prevent immune rejection in humanized mice.

Authors:  Nikolai Klymiuk; Lelia van Buerck; Andrea Bähr; Monika Offers; Barbara Kessler; Annegret Wuensch; Mayuko Kurome; Michael Thormann; Katharina Lochner; Hiroshi Nagashima; Nadja Herbach; Rüdiger Wanke; Jochen Seissler; Eckhard Wolf
Journal:  Diabetes       Date:  2012-04-20       Impact factor: 9.461

5.  Dual fluorescent reporter pig for Cre recombination: transgene placement at the ROSA26 locus.

Authors:  Shun Li; Tatiana Flisikowska; Mayuko Kurome; Valeri Zakhartchenko; Barbara Kessler; Dieter Saur; Alexander Kind; Eckhard Wolf; Krzysztof Flisikowski; Angelika Schnieke
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

6.  Developments of reproductive management and biotechnology in the pig.

Authors:  Olli Peltoniemi; Stefan Björkman; Marianne Oropeza-Moe; Claudio Oliviero
Journal:  Anim Reprod       Date:  2019-10-23       Impact factor: 1.807

7.  Growth hormone receptor-deficient pigs resemble the pathophysiology of human Laron syndrome and reveal altered activation of signaling cascades in the liver.

Authors:  Arne Hinrichs; Barbara Kessler; Mayuko Kurome; Andreas Blutke; Elisabeth Kemter; Maren Bernau; Armin M Scholz; Birgit Rathkolb; Simone Renner; Sebastian Bultmann; Heinrich Leonhardt; Martin Hrabĕ de Angelis; Hiroshi Nagashima; Andreas Hoeflich; Werner F Blum; Martin Bidlingmaier; Rüdiger Wanke; Maik Dahlhoff; Eckhard Wolf
Journal:  Mol Metab       Date:  2018-03-15       Impact factor: 7.422

8.  Laparoscopy vs. laparotomy for embryo transfer to produce transgenic goats (Capra hircus).

Authors:  Sang Tae Shin; Sung Keun Jang; Hong Suk Yang; Ok Keun Lee; Yhong Hee Shim; Won Il Choi; Doo Soo Lee; Gwan Sun Lee; Jong Ki Cho; Young Won Lee
Journal:  J Vet Sci       Date:  2008-03       Impact factor: 1.672

9.  Factors influencing the efficiency of generating genetically engineered pigs by nuclear transfer: multi-factorial analysis of a large data set.

Authors:  Mayuko Kurome; Ludwig Geistlinger; Barbara Kessler; Valeri Zakhartchenko; Nikolai Klymiuk; Annegret Wuensch; Anne Richter; Andrea Baehr; Katrin Kraehe; Katinka Burkhardt; Krzysztof Flisikowski; Tatiana Flisikowska; Claudia Merkl; Martina Landmann; Marina Durkovic; Alexander Tschukes; Simone Kraner; Dirk Schindelhauer; Tobias Petri; Alexander Kind; Hiroshi Nagashima; Angelika Schnieke; Ralf Zimmer; Eckhard Wolf
Journal:  BMC Biotechnol       Date:  2013-05-20       Impact factor: 2.563

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.